Acuvi Balance Sheet Health
Financial Health criteria checks 4/6
Acuvi has a total shareholder equity of SEK410.1M and total debt of SEK44.1M, which brings its debt-to-equity ratio to 10.7%. Its total assets and total liabilities are SEK529.9M and SEK119.8M respectively. Acuvi's EBIT is SEK25.1M making its interest coverage ratio -4.2. It has cash and short-term investments of SEK15.2M.
Key information
10.75%
Debt to equity ratio
SEK 44.06m
Debt
| Interest coverage ratio | -4.2x |
| Cash | SEK 15.19m |
| Equity | SEK 410.06m |
| Total liabilities | SEK 119.80m |
| Total assets | SEK 529.86m |
Recent financial health updates
Acuvi (STO:ACUVI) Is Carrying A Fair Bit Of Debt
Oct 31
We Think Acuvi (STO:ACUVI) Has A Fair Chunk Of Debt
Mar 07Recent updates
Market Participants Recognise Acuvi AB's (STO:ACUVI) Revenues
Apr 04Acuvi (STO:ACUVI) Is Carrying A Fair Bit Of Debt
Oct 31Investors Continue Waiting On Sidelines For Acuvi AB (STO:ACUVI)
Aug 07Further Upside For Acuvi AB (STO:ACUVI) Shares Could Introduce Price Risks After 46% Bounce
Apr 24We Like These Underlying Return On Capital Trends At Acuvi (STO:ACUVI)
Apr 18We Think Acuvi (STO:ACUVI) Has A Fair Chunk Of Debt
Mar 07Acuvi AB (STO:ACUVI) Shares Fly 27% But Investors Aren't Buying For Growth
Jan 03Acuvi AB's (STO:ACUVI) Price Is Out Of Tune With Revenues
Jul 08One Acuvi AB (STO:ACUVI) Broker Just Cut Their Revenue Forecasts By 13%
May 12This Broker Just Slashed Their Acuvi AB (STO:ACUVI) Earnings Forecasts
Mar 16Financial Position Analysis
Short Term Liabilities: ACUVI's short term assets (SEK115.7M) exceed its short term liabilities (SEK78.7M).
Long Term Liabilities: ACUVI's short term assets (SEK115.7M) exceed its long term liabilities (SEK41.1M).
Debt to Equity History and Analysis
Debt Level: ACUVI's net debt to equity ratio (7%) is considered satisfactory.
Reducing Debt: ACUVI's debt to equity ratio has increased from 7% to 10.7% over the past 5 years.
Debt Coverage: ACUVI's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: ACUVI earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/20 08:22 |
| End of Day Share Price | 2025/05/20 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Acuvi AB is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Henrik Alveskog | Redeye |
| Erika Madebrink | Redeye |